The goal of the Fintepla REMS is to mitigate the risk of valvular heart disease and pulmonary arterial hypertension, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.
pending May 2026 P&T Committee review
The goal of the Fintepla REMS is to mitigate the risk of valvular heart disease and pulmonary arterial hypertension, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.